Novo Nordisk A/S Common Stock (NVO)
SG&A Expense Growth
4.31%
Fiscal year · Period ending:
NVO SG&A Expense Growth
Latest reported4.31%period ending
Latest reported4.31%period ending
NVO FY SG&A Growth (YoY) (0.00% → 4.31%)
Latest values, visible window
High-resolution chart · PNG
NVO sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 4.3071% | |
| 9.3818% | |
| 21.5334% | |
| 23.4449% | |
| 11.3105% | |
| 2.9473% | |
| 7.5556% | |
| 3.7013% | |
| -0.6648% | |
| 0.5285% | |
| 20.213% | |
| -0.476% | |
| 8.1751% | |
| 11.7174% | |
| 4.6519% | |
| 16.916% | |
| 14.9218% | |
| 6.215% | |
| 6.4341% | |
| 18.6675% | |
| 14.5663% | |
| 6.4297% | |
| 2.6832% | |
| 4.0268% | |
| 14.1533% | |
| 24.7716% | |
| 18.5591% | |
| -10.8662% | |
| -21.7527% | |
| 11.8882% | |
| 1.2189% | |
| 69.9549% | |
| -36.5096% | |
| 107.0838% | |
| 15.3577% | |
| 12.9224% | |
| 41.0871% | |
| 8.4686% | |
| 0% | |
| -100% | |
| 0% |